PREVALENCE OF EXTRAINTESTINAL MANIFESTATIONS AMONG PATIENTS WITH ULCERATIVE COLITIS

Main Article Content

Noman Khan
Wajid Iqbal
Younas Ahmad
Shah Nawaz Khatti
Asma Abdul Razzak
Vineesha

Keywords

Ulcerative colitis, Extraintestinal manifestations, predictors

Abstract

Objective: Prevalence of extraintestinal manifestations among patients with ulcerative colitis.


Methodology: We initiated a cross sectional study on 180 patients presenting with ulcerative colitis having age 18 to 65 years of either gender. Prevalence of EIMs and its predictors were assessed.


Results: The mean age was 40.77±14.20 years. Prevalence of EIMs was 84 (46.7%). Nineteen (22.6%) EIM patients had pancolitis, Thirty six (42.9%) had arthritis, and 23 (27.4%) had colectomy. Predictors such pancolitis, arthritis, and colectomy were connected to extraintestinal symptoms.


Conclusion: Prevalence of extraintestinal manifestations among patients with ulcerative colitis was 84 (46.7%)

Abstract 83 | PDF Downloads 40

References

1. Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65(12):100851.
2. Gros B, Kaplan GG. Ulcerative colitis in adults. JAMA. 2023;330(10):951-65.
3. Segal JP, LeBlanc JF, Hart AL. Ulcerative colitis: an update. Clin Med. 2021;21(2):135-42.
4. Hata K, Okada S, Shinagawa T, Toshiaki T, Kawai K, Nozawa H. Meta-analysis of the association of extraintestinal manifestations with the development of pouchitis in patients with ulcerative colitis. BJS Open. 2019;3(4):436-44.
5. Marotto D, Atzeni F, Ardizzone S, Monteleone G, Giorgi V, Sarzi-Puttini P. Extra-intestinal manifestations of inflammatory bowel diseases. Pharmacol Res. 2020;161:105206.
6. Guillo L, D’amico F, Serrero M, Angioi K, Loeuille D. Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials. United European Gastroenterol J. 2020;8(9):1013-30.
7. Kim JM, Cheon JH. Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases. Intest Res. 2020;18(3):249-64.
8. Olpin JD, Sjoberg BP, Stilwill SE, Jensen LE, Rezvani M, Shaaban AM. Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease. Radiographics. 2017;37(4):1135-60.
9. Woźniak M, Kurnatowska I, Małecka-Panas E, Talar-Wojnarowska R. Leukocytapheresis in patients with inflammatory bowel diseases. Gastroenterology. 2021;16(2):99-105.
10. Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease–epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol. 2019;13(4):307-17.
11. Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut. 1996;38(5):738.
12. Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10(10):585-95.
13. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease: a prospective study of 792 patients. J Clin Gastroenterol. 1996;23(1):29-34.
14. Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:63–8.
15. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–9.
16. Peeters H, Vander Cruyssen B, Mielants H, de Vlam K, Vermeire S, Louis E, et al. Clinical and genetic factors associated with sacroiliitis in Crohn's disease. J Gastroenterol Hepatol. 2008;23:132–7.
17. Leclerc-Jacob S, Lux G, Rat AC, Laurent V, Blum A, Chary-Valckenaere I, et al. The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: A retrospective study performed on 186 patients. Aliment Pharmacol Ther. 2014;39:957–62.
18. Yamamoto-Furusho JK, Sánchez-Morales GE. Factors Associated with the Presence of Extraintestinal Manifestations in Patients with Ulcerative Colitis in a Latin American Country. Inflamm Intestin Dis. 2020;5(4):200-4.
19. Hernandez-Tejero M, Granja-Navacerrada A, Bernal-Checa P, Pique-Becerra R, Algaba-Garcia A, Guerra-Marina I, et al. Prevalence, risk factors and response to treatment of extraintestinal manifestations in patients with inflammatory bowel disease. Revista Espanola de Enfermadades Digestivas (REED). 2017;109(9):627-33.

Most read articles by the same author(s)